Roche's $595M diagnostic bet & leadership reshuffles
Supply Chain Pulse — 2026-04-20
Roche is betting big on the future of cancer diagnostics, dropping $595 million to acquire MRD testing specialist Saga Diagnostics in what Foundation Medicine calls "one of the fastest-growing areas within diagnostics." Meanwhile, health system leadership is in flux with three major CEO transitions announced, signaling potential shifts in procurement strategies and vendor relationships. This week's moves suggest consolidation is accelerating in both diagnostics and health system management—worth tracking how these changes impact your vendor negotiations and testing portfolios.
Quick Hits
- ChristianaCare CEO Dr. Janice Nevin to retire in September, replaced by CSO Jenn Schwartz (Modern Healthcare)
- WellSpan Health CEO Roxanna Gapstur announces retirement after 5-year tenure (Modern Healthcare)
- Digital health funding hits $4B across 110 Q1 deals, driven by megadeals (Modern Healthcare)
- Health insurers pivot venture capital strategies as CVS, Optum, Cigna hold dozens of startup investments (Modern Healthcare)
- HPN opens 2026 Supply Chain Department of the Year award entries (Healthcare Purchasing News)
Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout
Roche's Foundation Medicine subsidiary acquired MRD (minimal residual disease) testing specialist Saga Diagnostics for $595 million, targeting what they call "one of the fastest-growing areas within diagnostics." This consolidation in cancer diagnostics could reshape testing portfolios and pricing as Roche expands its oncology testing dominance. Expect potential disruptions to existing MRD testing contracts and supply agreements as integration unfolds.
Source: Medical Device Network
Pulnovo completes $100m financing round with Medtronic investment
Medtronic led a $100 million oversubscribed financing round in Pulnovo Medical, a move that signals the medtech giant's strategic interest in the company's pulmonary embolism treatment technology. This partnership could accelerate Pulnovo's market penetration and potentially create preferred supplier pathways through Medtronic's distribution network. Watch for bundling opportunities or exclusive arrangements that could impact your cardiovascular device sourcing.
Source: Medical Device Network
How new CEO John D'Angelo is reshaping Northwell Health
Six months into his tenure, Northwell Health's new CEO Dr. John D'Angelo is implementing strategic changes at the 21-hospital New York system. Leadership transitions at major health systems often trigger supply chain strategy reviews and vendor relationship resets. If you're a Northwell supplier or considering partnerships with large health systems, track how new leadership priorities might shift procurement focus and contract renewal timelines.
AdventHealth growth strategy emerges after primary care restructuring
AdventHealth CEO David Banks reports "big results" from restructuring primary care operations one year into his leadership. The 50+ hospital system's primary care pivot could drive changes in outpatient supply needs, from point-of-care diagnostics to chronic care management tools. Systems refocusing on primary care typically increase spending on ambulatory-specific products while potentially reducing acute care volumes.
Baylor Scott & White Health Plan exits Medicaid, exchange markets
Baylor Scott & White Health Plan is eliminating 321 jobs as it withdraws from Medicaid and ACA exchange markets, signaling financial pressures in the insurance arm of the major Texas health system. When health system insurance plans contract, it can impact utilization patterns and reimbursement strategies across their provider networks. This move might influence the system's approach to cost containment and supplier contract negotiations.
U.S. Measles Cases Grow to 1,714
Measles cases continue climbing to 1,714, putting the U.S. on track to lose its elimination status this year despite last week's smaller increase. This outbreak is driving demand for MMR vaccines, isolation supplies, and infection prevention products. Stock up on contact precaution supplies and coordinate with your infectious disease teams on vaccination inventory—this trajectory suggests sustained pressure on prevention resources through 2026.
Source: Healthcare Purchasing News
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe